Skip to main content
NUWE logo

NUWE · Nuwellis, Inc. · Metrics

Track NUWE — free
$3.50 -0.31 (-8.14%) Play latest call Q2 2026 earnings call transcript
Market Cap
$2.06M
Shares
540,912
Volume · Nov 20 4835 Avg daily vol (18 sessions) 2.34M

NUWE metrics

61 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.81
Market cap
$2.06M

Price action

23 metrics
Price change (1W)
-24.3%
Price change (30D)
-29.6%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$146.65
52-week low
$0.32
Change from 52-week high
-97.4%
Change from 52-week low
+1,090.6%
Annualized volatility
—
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
35.5
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
540,912

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 504,205.5%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 437.1%
P / book
0.2
reciprocal yield 477.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-667.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-1.5×
EV / revenue historical average (5Y)
-1.5×
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-12

Profitability

9 metrics
Gross margin
70.8%
Operating margin
-135.8%
Trailing 12 months
Net margin
-152.8%
Gross profit (TTM)
$6.37M
Operating profit (TTM)
−$12.23M
Net income (TTM)
−$13.76M
Trailing 12 months
Diluted EPS (TTM)
$19,210.23
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$491.20

Growth

11 metrics
Revenue growth YoY
-0.2%
Year over year
Net income growth YoY
-520.7%
Revenue (TTM)
$9.01M
Trailing 12 months
EPS growth YoY
-103.3%
Shares change YoY
+12,688.5%
Year over year · more shares
Revenue CAGR (3Y)
-1.1%
Revenue CAGR (5Y)
+2.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-139.8%
Return on assets
-102.3%
Debt / equity
—
Current ratio
4.0
EBITDA (TTM)
−$12.09M
Free cash flow (TTM)
—
Quick ratio
3.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$8.29M
Total assets
$13.45M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$12.30M
Capital expenditures (TTM)
$5,000
R&D (TTM)
$4.14M
SG&A (TTM)
$14.47M
Stock compensation (TTM)
$79,000
R&D / revenue
45.9%
Stock compensation / revenue
0.9%

Ownership (13F)

9 metrics
13F filers
11
13F filer change QoQ
+6
Institutional ownership
6.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
4.8%
Private-fund adviser ownership
1.9%
Active holders' share change QoQ
+5,795.5%
Holder tenure
1.4
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
36.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
79 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1506492 CUSIP 67113Y884 13F (30d) 15 filings 12 filers Visit website Investor relations